Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Nymox updates the FDA in regard to their phase III program for NX-1207

Feb. 20, 2009

Astellas patent covers EP4 receptor antagonists and their use in treating chronic renal failure

Feb. 13, 2009

Daiichi Sankyo and Kissei to launch Urief tablets for Dysuria in Japan

Feb. 4, 2009

Novel tachykinin NK1 receptor antagonists identified by Merck & Co. researchers

Feb. 3, 2009

Gelnique gel approved by the FDA for overactive bladder

Jan. 29, 2009

Protox commences placebo-controlled phase II BPH study

Jan. 15, 2009

Plexxikon and Roche partner to develop PLX-5568 for polycystic kidney disease

Jan. 9, 2009

Daiichi files application for KMD-3212 in China for dysuria

Jan. 9, 2009

BioXell completes patient enrollment in phase IIb clinical trial of elocalcitol in OAB

Dec. 22, 2008

NX-1207 shows significantly less sleep interruption for men with BPH

Dec. 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...